1. Home
  2. Global Antimicrobial Resistance Innovation Fund (GAMRIF) - Vaccine Innovation with the Bacterial Vaccinology Network (BactiVac)
UK - Department of Health and Social Care (DHSC)

Global Antimicrobial Resistance Innovation Fund (GAMRIF) - Vaccine Innovation with the Bacterial Vaccinology Network (BactiVac)

IATI Identifier: GB-GOV-10-GAMRIF-BACTIVAC
Project disclaimer
Disclaimer: The data for this page has been produced from IATI data published by UK - Department of Health and Social Care (DHSC).

Description

This is an Official Development Assistance (ODA) funded UKaid programme from the Department of Health and Social Care (DHSC)'s Global Antimicrobial Resistance Innovation Fund (GAMRIF) delivered in partnership with the Bacterial Vaccinology Network (BactiVac) to support the development of vaccines for antimicrobial resistance (AMR) in humans and animals. BactiVac is one of five networks that are supported by the Global Challenges Research Fund (GCRF) Networks in Vaccines Research and Development. This is co-funded by the UK Medical Research Council (MRC) and UK Biotechnology and Biological Sciences Research Council (BBSRC). The primary aim of this investment is to accelerate the development of vaccines against bacterial infections aimed at reducing antimicrobial use in humans and animals, relevant to low-and-middle-income countries (LMICs). This investment also supports new, diverse research projects to gain preliminary data and encourage new research partnerships, and allow these collaborations to build a track record, which will allow them to obtain further funding. It is expected that some of these projects will not yield expected research results, yet the dissemination of both positive and negative research outcomes is valuable and expected. Funded projects will undertake early-stage research and development with catalyst pump-priming funding around the world to help drive the development and uptake of vaccines for AMR for the benefit of people in LMICs. Projects funded through GAMRIF will primarily benefit people in LMICs, where the burden of drug-resistant infection is greater.


Location

The country, countries or regions that benefit from this Programme.
Developing countries, unspecified
Disclaimer: Country borders do not necessarily reflect the UK Government's official position.

Status Implementation

The current stage of the Programme, consistent with the International Aid Transparency Initiative's (IATI) classifications.

Programme Spend

Programme budget and spend to date, as per the amounts loaded in financial system(s), and for which procurement has been finalised.

Participating Organisation(s)

Help with participating organisations

Accountable:Organisation responsible for oversight of the activity

Extending: Organisation that manages the budget on behalf of the funding organisation.

Funding: Organisation which provides funds.

Implementing: Organisations implementing the activity.

Sectors

Sector groups as a percentage of total Programme budget according to the OECD Development Assistance Committee (DAC) classifications.

Budget

A comparison across financial years of forecast budget and spend to date on the Programme.

Download IATI Data for GB-GOV-10-GAMRIF-BACTIVAC